Now, the shift is clear: Broader access through generics Lower costs across healthcare systems Increased competition and innovation Stronger recognition of obesity as a treatable disease This is more than a patent expiry, its a turning point in global metabolic health
SES Numerically, Not Statistically, Superior to ZES at 5-Years in SUGAR Study Mar 07, 2026 by Natalie Morrison, CRTonline.org A sirolimus-eluting stent (SES) saw a numerical improvement in target lesion failure (TLF) rates for diabetes mellitus (DM) at 5-year follow-up compared to a zotarolimus-eluting stent (ZES) but did not maintain the 1-year statistical significance, the latest report from the SUGAR study shows
Each time the dose increases, the same weekly injection routine continues
In addition, there was evidence of a significant reduction in average loop diuretic dose, a lower likelihood of diuretic treatment escalation, and a greater likelihood of diuretic treatment de-escalation with semaglutide versus placeboparameters that indicate disease-modifying effects of semaglutide, and are associated with better long-term clinical outcomes in this patient population. Photo 288328289 Fernanda Carrasco | Dreamstime.com
If the body loses too much fluid due to vomiting or diarrhea, it can lead to acute kidney injury
What happens when your body is low on glutathione
.jpg)
